Inactive Instrument
InterCure Ltd. Stock TEL AVIV STOCK EXCHANGE
Stocks
INCR
IL0011063760
Healthcare Facilities & Services
| Market Cap | 166M 506M 144M 135M 124M 233M 15.83B 237M 1.59B 622M 7.9B 624M 610M 26.04B | P/E 2024 |
-4.01x | P/E 2025 | -4.87x |
|---|---|---|---|---|---|
| Enterprise Value | 302M 922M 263M 245M 225M 425M 28.83B 432M 2.89B 1.13B 14.38B 1.14B 1.11B 47.42B | EV / Sales 2024 |
1.69x | EV / Sales 2025 | 1.16x |
| Free-Float |
60.83% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.22% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | 24/12/2019 | |
Amos Cohen
DFI | Director of Finance/CFO | 47 | 01/03/2020 |
Itai Kabiljo
LAW | General Counsel | - | 01/04/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 50 | 03/09/2015 | |
David Salton
BRD | Director/Board Member | 66 | 14/12/2014 |
| Chairman | 55 | 13/02/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.22% | -0.51% | - | - | 56.18M | |
| +1.04% | +0.52% | +25.97% | +228.81% | 219M | |
| -3.68% | -0.76% | -29.19% | -31.05% | 131M | |
| -1.06% | -2.11% | -1.06% | +75.47% | 131M | |
| -0.02% | +4.97% | -30.00% | -2.33% | 83.89M | |
| -.--% | -.--% | -.--% | -37.10% | 79.16M | |
| Average | -0.58% | -0.68% | -6.86% | +46.76% | 128.98M | |
| Weighted average by Cap. | -0.55% | -0.76% | -1.23% | +82.00% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 239M 728M 208M 194M 178M 335M 22.77B 341M 2.29B 895M 11.35B 897M 877M 37.45B | 270M 823M 235M 219M 201M 380M 25.75B 386M 2.59B 1.01B 12.84B 1.01B 992M 42.36B |
| Net income | -67.8M -207M -58.92M -55.01M -50.5M -95.22M -6.46B -96.88M -649M -254M -3.22B -255M -249M -10.63B | -35.71M -109M -31.04M -28.98M -26.6M -50.16M -3.4B -51.03M -342M -134M -1.7B -134M -131M -5.6B |
| Net Debt | 133M 405M 115M 108M 98.89M 186M 12.65B 190M 1.27B 497M 6.31B 499M 488M 20.81B | 136M 416M 118M 111M 102M 191M 13B 195M 1.3B 511M 6.48B 512M 501M 21.37B |
Employees
-
